557 related articles for article (PubMed ID: 29321225)
1. Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism.
Song WM; Joshita S; Zhou Y; Ulland TK; Gilfillan S; Colonna M
J Exp Med; 2018 Mar; 215(3):745-760. PubMed ID: 29321225
[TBL] [Abstract][Full Text] [Related]
2. Prior activation state shapes the microglia response to antihuman TREM2 in a mouse model of Alzheimer's disease.
Ellwanger DC; Wang S; Brioschi S; Shao Z; Green L; Case R; Yoo D; Weishuhn D; Rathanaswami P; Bradley J; Rao S; Cha D; Luan P; Sambashivan S; Gilfillan S; Hasson SA; Foltz IN; van Lookeren Campagne M; Colonna M
Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33446504
[TBL] [Abstract][Full Text] [Related]
3. A Trem2
Tran KM; Kawauchi S; Kramár EA; Rezaie N; Liang HY; Sakr JS; Gomez-Arboledas A; Arreola MA; Cunha CD; Phan J; Wang S; Collins S; Walker A; Shi KX; Neumann J; Filimban G; Shi Z; Milinkeviciute G; Javonillo DI; Tran K; Gantuz M; Forner S; Swarup V; Tenner AJ; LaFerla FM; Wood MA; Mortazavi A; MacGregor GR; Green KN
Mol Neurodegener; 2023 Feb; 18(1):12. PubMed ID: 36803190
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease-associated R47H TREM2 increases, but wild-type TREM2 decreases, microglial phagocytosis of synaptosomes and neuronal loss.
Popescu AS; Butler CA; Allendorf DH; Piers TM; Mallach A; Roewe J; Reinhardt P; Cinti A; Redaelli L; Boudesco C; Pradier L; Pocock JM; Thornton P; Brown GC
Glia; 2023 Apr; 71(4):974-990. PubMed ID: 36480007
[TBL] [Abstract][Full Text] [Related]
5. Triggering Receptor Expressed on Myeloid Cell 2 R47H Exacerbates Immune Response in Alzheimer's Disease Brain.
Korvatska O; Kiianitsa K; Ratushny A; Matsushita M; Beeman N; Chien WM; Satoh JI; Dorschner MO; Keene CD; Bammler TK; Bird TD; Raskind WH
Front Immunol; 2020; 11():559342. PubMed ID: 33101276
[TBL] [Abstract][Full Text] [Related]
6. iPSC-derived microglia carrying the TREM2 R47H/+ mutation are proinflammatory and promote synapse loss.
Penney J; Ralvenius WT; Loon A; Cerit O; Dileep V; Milo B; Pao PC; Woolf H; Tsai LH
Glia; 2024 Feb; 72(2):452-469. PubMed ID: 37969043
[TBL] [Abstract][Full Text] [Related]
7. TREM2 Alzheimer's variant R47H causes similar transcriptional dysregulation to knockout, yet only subtle functional phenotypes in human iPSC-derived macrophages.
Hall-Roberts H; Agarwal D; Obst J; Smith TB; Monzón-Sandoval J; Di Daniel E; Webber C; James WS; Mead E; Davis JB; Cowley SA
Alzheimers Res Ther; 2020 Nov; 12(1):151. PubMed ID: 33198789
[TBL] [Abstract][Full Text] [Related]
8. Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) R47H Variant Causes Distinct Age- and Sex-Dependent Musculoskeletal Alterations in Mice.
Essex AL; Huot JR; Deosthale P; Wagner A; Figueras J; Davis A; Damrath J; Pin F; Wallace J; Bonetto A; Plotkin LI
J Bone Miner Res; 2022 Jul; 37(7):1366-1381. PubMed ID: 35575023
[TBL] [Abstract][Full Text] [Related]
9. Plaque contact and unimpaired Trem2 is required for the microglial response to amyloid pathology.
Wood JI; Wong E; Joghee R; Balbaa A; Vitanova KS; Stringer KM; Vanshoiack A; Phelan SJ; Launchbury F; Desai S; Tripathi T; Hanrieder J; Cummings DM; Hardy J; Edwards FA
Cell Rep; 2022 Nov; 41(8):111686. PubMed ID: 36417868
[TBL] [Abstract][Full Text] [Related]
10. Microglial activation, tau and amyloid deposition in TREM2 p.R47H carriers and mild cognitive impairment patients: a multi-modal/multi-tracer PET/MRI imaging study with influenza vaccine immune challenge.
Cousins O; Schubert JJ; Chandra A; Veronese M; Valkimadi P; Creese B; Khan Z; Arathimos R; Hampshire A; Rosenzweig I; Ballard C; Corbett A; Aasland D; Velayudhan L; O'Neill M; Collier D; Awais R; Sander K; Årstad E; Howes O; Turkheimer F; Hodges A
J Neuroinflammation; 2023 Nov; 20(1):272. PubMed ID: 37990275
[TBL] [Abstract][Full Text] [Related]
11. TNF-α-mediated reduction in inhibitory neurotransmission precedes sporadic Alzheimer's disease pathology in young Trem2
Ren S; Breuillaud L; Yao W; Yin T; Norris KA; Zehntner SP; D'Adamio L
J Biol Chem; 2021; 296():100089. PubMed ID: 33434745
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer risk-increasing TREM2 variant causes aberrant cortical synapse density and promotes network hyperexcitability in mouse models.
Das M; Mao W; Voskobiynyk Y; Necula D; Lew I; Petersen C; Zahn A; Yu GQ; Yu X; Smith N; Sayed FA; Gan L; Paz JT; Mucke L
Neurobiol Dis; 2023 Oct; 186():106263. PubMed ID: 37591465
[TBL] [Abstract][Full Text] [Related]
13. SHIP inhibition mediates select TREM2-induced microglial functions.
Ramakrishnan GS; Berry WL; Pacherille A; Kerr WG; Chisholm JD; Pedicone C; Humphrey MB
Mol Immunol; 2024 Jun; 170():35-45. PubMed ID: 38613944
[TBL] [Abstract][Full Text] [Related]
14. Trem2 Y38C mutation and loss of Trem2 impairs neuronal synapses in adult mice.
Jadhav VS; Lin PBC; Pennington T; Di Prisco GV; Jannu AJ; Xu G; Moutinho M; Zhang J; Atwood BK; Puntambekar SS; Bissel SJ; Oblak AL; Landreth GE; Lamb BT
Mol Neurodegener; 2020 Oct; 15(1):62. PubMed ID: 33115519
[TBL] [Abstract][Full Text] [Related]
15. TREM2 drives microglia response to amyloid-β via SYK-dependent and -independent pathways.
Wang S; Sudan R; Peng V; Zhou Y; Du S; Yuede CM; Lei T; Hou J; Cai Z; Cella M; Nguyen K; Poliani PL; Beatty WL; Chen Y; Cao S; Lin K; Rodrigues C; Ellebedy AH; Gilfillan S; Brown GD; Holtzman DM; Brioschi S; Colonna M
Cell; 2022 Oct; 185(22):4153-4169.e19. PubMed ID: 36306735
[TBL] [Abstract][Full Text] [Related]
16. Sleep deprivation exacerbates microglial reactivity and Aβ deposition in a
Parhizkar S; Gent G; Chen Y; Rensing N; Gratuze M; Strout G; Sviben S; Tycksen E; Zhang Q; Gilmore PE; Sprung R; Malone J; Chen W; Remolina Serrano J; Bao X; Lee C; Wang C; Landsness E; Fitzpatrick J; Wong M; Townsend R; Colonna M; Schmidt RE; Holtzman DM
Sci Transl Med; 2023 Apr; 15(693):eade6285. PubMed ID: 37099634
[TBL] [Abstract][Full Text] [Related]
17. R47H TREM2 variant increases risk of typical early-onset Alzheimer's disease but not of prion or frontotemporal dementia.
Slattery CF; Beck JA; Harper L; Adamson G; Abdi Z; Uphill J; Campbell T; Druyeh R; Mahoney CJ; Rohrer JD; Kenny J; Lowe J; Leung KK; Barnes J; Clegg SL; Blair M; Nicholas JM; Guerreiro RJ; Rowe JB; Ponto C; Zerr I; Kretzschmar H; Gambetti P; Crutch SJ; Warren JD; Rossor MN; Fox NC; Collinge J; Schott JM; Mead S
Alzheimers Dement; 2014 Nov; 10(6):602-608.e4. PubMed ID: 25160042
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Trem2 activation ameliorates amyloid-beta deposition and improves cognition in the 5XFAD model of amyloid deposition.
Price BR; Sudduth TL; Weekman EM; Johnson S; Hawthorne D; Woolums A; Wilcock DM
J Neuroinflammation; 2020 Aug; 17(1):238. PubMed ID: 32795308
[TBL] [Abstract][Full Text] [Related]
19. TREM2 variants in Alzheimer's disease.
Guerreiro R; Wojtas A; Bras J; Carrasquillo M; Rogaeva E; Majounie E; Cruchaga C; Sassi C; Kauwe JS; Younkin S; Hazrati L; Collinge J; Pocock J; Lashley T; Williams J; Lambert JC; Amouyel P; Goate A; Rademakers R; Morgan K; Powell J; St George-Hyslop P; Singleton A; Hardy J;
N Engl J Med; 2013 Jan; 368(2):117-27. PubMed ID: 23150934
[TBL] [Abstract][Full Text] [Related]
20. Identification of senescent, TREM2-expressing microglia in aging and Alzheimer's disease model mouse brain.
Rachmian N; Medina S; Cherqui U; Akiva H; Deitch D; Edilbi D; Croese T; Salame TM; Ramos JMP; Cahalon L; Krizhanovsky V; Schwartz M
Nat Neurosci; 2024 Jun; 27(6):1116-1124. PubMed ID: 38637622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]